The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative

NCT ID: NCT03480854

Last Updated: 2021-05-07

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 694 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2017-07-01
• Study Completion Date: 2020-12-31

Brief Summary

To establish the first systems level continuous quality improvement (CQI) collaborative for multiple sclerosis (MS) in the United States, to conduct benchmarking analyses and assessments of geographic variation in MS care quality and value, and study the effect of CQI interventions on improvement of selected performance (quality) indicators.

Detailed Description

This is a three year study which employed a step-wedge randomized design which exposed three of four participating centers to a healthcare QI intervention during the 3 year period. Each of the centers exposed to an intervention served as its own control during a baseline pre-intervention period during the first year of the study. The fourth site served as a longitudinal control for comparison to the other three centers exposed to a QI intervention.

Conditions

Multiple Sclerosis

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: HEALTH_SERVICES_RESEARCH
• Blinding Strategy: NONE

Study Groups

Baseline Analysis

To conduct studies of variation in performance across microsystems and to utilize benchmarking analyses to identify top performers.

Group Type: NO_INTERVENTION

No interventions assigned to this group

The effect of continuous quality improvements (CQI)

To study the comparative improvement of selected primary process performance indicators (DMT and MRI process measures) over a 3 year period (Years 2-3) in microsystems receiving CQI interventions versus those not receiving CQI intervention, and between two different CQI intervention types (IHI Breakthrough Series and Patient Centered Medical Home).

Group Type: EXPERIMENTAL

Quality Improvement

Intervention Type: OTHER

Randomly selected sites will receive one of two system level improvement approaches; 1) patient centered specialty medical home certification 2) IHI Breakthrough Series improvement approach with professional improvement coaching.

Interventions

Quality Improvement

Randomly selected sites will receive one of two system level improvement approaches; 1) patient centered specialty medical home certification 2) IHI Breakthrough Series improvement approach with professional improvement coaching.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Adults aged 18 years or older with documented clinically confirmed MS who are followed by one of the participating MS centers.

Exclusion Criteria

• Candidates will be excluded from study entry if they are unable or unwilling to provide informed consent.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

MGH Multiple Sclerosis Clinic

UNKNOWN

Sponsor Role: collaborator

University of Vermont

OTHER

Sponsor Role: collaborator

Neurology Associates Multiple Sclerosis Center of Greater Orlando

UNKNOWN

Sponsor Role: collaborator

Concord Hospital

OTHER

Sponsor Role: collaborator

Dartmouth-Hitchcock Medical Center

OTHER

Sponsor Role: lead

Responsible Party

Brant J. Oliver

Assistant Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Brant J Oliver, PhD

Role: PRINCIPAL_INVESTIGATOR

Dartmouth Hitchock

Locations

Neurology Associates of Greater Orlando

Maitland, Florida, United States

Massachusetts General Hospital Multiple Sclerosis Center

Boston, Massachusetts, United States

Concord Hospital

Concord, New Hampshire, United States

University of Vermont Multiple Sclerosis Center

Burlington, Vermont, United States

Countries

United States

Other Identifiers

US-MSG-15-10917

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

D16181

Identifier Type: -

Identifier Source: org_study_id